OKE
64
-3
PEG
50
4
ZBH
45
3
SLG
37
6
DRI
64
4
PG
43
2
ALLE
48
2
TGT
52
2
ETN
61
2
SIG
52
2
KMB
33
2
JNJ
54
3
FSLR
60
-10
RRC
68
-2
GT
39
2
GS
78
2
A
46
2
DLTR
58
3
FTI
61
-2
KO
44
2
OKE
64
-3
PEG
50
4
ZBH
45
3
SLG
37
6
DRI
64
4
PG
43
2
ALLE
48
2
TGT
52
2
ETN
61
2
SIG
52
2
KMB
33
2
JNJ
54
3
FSLR
60
-10
RRC
68
-2
GT
39
2
GS
78
2
A
46
2
DLTR
58
3
FTI
61
-2
KO
44
2
Financhill
Back

Avantis Emerging Markets Value ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
66

AVES
Avantis Emerging Markets Value ETF

Last Price:
$58.33
Seasonality Move:
0.61%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
66
Avantis Emerging Markets Value ETF (AVES) is a Buy

Is Avantis Emerging Markets Value ETF a Buy, Sell or Hold?

  • The current Avantis Emerging Markets Value ETF [AVES] share price is $58.33. The Score for AVES is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AVES is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AVES Stock Price Chart

What is Avantis Emerging Markets Value ETF's stock price today?

  • The Avantis Emerging Markets Value ETF share price today is $58.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVES is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

AVES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 54.86 Buy
Chaikin Money Flow: 4391 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.17 - 58.41) Buy
Bollinger Bands (100): (55.94 - 58.32) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

AVES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.61 Buy
20-day SMA: 57.95 Buy
50-day SMA: 57.93 Buy
200-day SMA: 53.75 Buy
8-day EMA: 57.8 Buy
20-day EMA: 57.85 Buy
50-day EMA: 57.69 Buy
200-day EMA: 54.65 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Avantis Emerging Markets Value ETF Earnings Growth & AVES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Avantis Emerging Markets Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):